Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression

Author:

Muñóz-Godínez Ricardo12ORCID,de Lourdes Mora-García María3ORCID,Weiss-Steider Benny3ORCID,Montesinos-Montesinos Juan José4ORCID,del Carmen Aguilar-Lemarroy Adriana5ORCID,García-Rocha Rosario3ORCID,Hernández-Montes Jorge3ORCID,Azucena Don-López Christian3ORCID,Ávila-Ibarra Luis Roberto13ORCID,Torres-Pineda Daniela Berenice1ORCID,Molina-Castillo Gabriela3ORCID,Chacón-Salinas Rommel67ORCID,Vallejo-Castillo Luis68ORCID,Pérez-Tapia Sonia Mayra679ORCID,Monroy-García Alberto123ORCID

Affiliation:

1. Laboratorio de Inmunología y Cáncer, Unidad de Investigación Médica en Enfermedades Oncológicas, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico

2. Programa de Posgrado en Ciencias Biológicas, UNAM, Ciudad de México, Mexico

3. Laboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, Mexico

4. Laboratorio de Células Troncales Mesenquimales, Unidad de Investigación Médica en Enfermedades Oncológicas, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico

5. Centro de Investigación Biomédica de Occidente División de Inmunología Sierra Mojada, No. 800, Col. Independencia, C.P. 44340 Guadalajara, Jalisco, Mexico

6. Unidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Instituto Politécnico Nacional, Ciudad de México, Mexico

7. Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, ENCB-IPN, Ciudad de México, Mexico

8. Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav-IPN), Ciudad de México, Mexico

9. Laboratorio Nacional para Servicios Especializados de Investigacioón, Desarrollo e Innovación (I + D + i) para Farmoquímicos y Biotecnológicos (LANSEIDI-FarBiotec-CONACyT), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico

Abstract

Persistent infection with high-risk human papillomavirus (HR-HPV) is the main factor in the development of cervical cancer (CC). The presence of immunosuppressive factors plays an important role in the development of this type of cancer. To determine whether CD39 and CD73, which participate in the production of immunosuppressive adenosine (Ado), are involved in the progression of CC, we compared the concentrations and hydrolytic activity of these ectonucleotidases in platelet-free plasma (PFP) samples between patients with low-grade squamous intraepithelial lesions (LSILs) ( n = 18 ), high-grade squamous intraepithelial lesions (HSILs) ( n = 12 ), and CC ( n = 19 ) and normal donors (NDs) ( n = 15 ). The concentrations of CD39 and CD73 in PFP increased with disease progression ( r = 0.5929 , p < 0.001 ). The PFP of patients with HSILs or CC showed the highest concentrations of CD39 (2.3 and 2.2 times that of the NDs, respectively) and CD73 (1.7 and 2.68 times that of the NDs, respectively), which were associated with a high capacity to generate Ado from the hydrolysis of adenosine diphosphate (ADP) and adenosine monophosphate (AMP). The addition of POM-1 and APCP, specific inhibitors of CD39 and CD73, respectively, inhibited the ADPase and AMPase activity of PFP by more than 90%. A high level of the 90 kD isoform of CD73 was detected in the PFP of patients with HSILs or CC. Digestion with endoglycosidase H and N-glycanase generated CD73 with weights of approximately 90 kD, 85 kD, 80 kD, and 70 kD. In addition, the levels of transforming grow factor-β (TGF-β) in the PFPs of patients with LSIL, HSIL and CC positively correlated with those of CD39 ( r = 0.4432 , p < 0.001 ) and CD73 ( r = 0.5786 , p < 0.001 ). These results suggest that persistent infection by HR-HPV and the concomitant production of TGF-β promote the expression of CD39 and CD73 to favor CC progression through Ado generation.

Funder

DGAPA-PAPIIT

Publisher

Hindawi Limited

Subject

Cell Biology,Immunology

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F. Bray;CA: A Cancer Journal of Clinicians,2018

2. The natural history of cervical HPV infection: unresolved issues

3. Biological agents. Volume 100 B. A review of human carcinogens;IARC Working Group;IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer,2012

4. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

5. Evasion of host immune defenses by human papillomavirus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3